文献速递心律失常

中国成人房颤患病率、知晓率与管理全国性调查

Atrial fibrillation prevalence, awareness and management in a nationwide survey of adults in China.
PubMed 文献 · Heart · 2021-01-28

知晓率低,高危房颤患者仅6.0%接受抗凝治疗。

要点

  • 房颤知晓率随年龄增长而下降,农村居民知晓率(35.3%)远低于城市(78.3%)。
  • 高危房颤患者中仅6.0%接受抗凝治疗,治疗缺口大。

核心结论

  • 中国房颤患病率高于既往报告,且知晓率低、治疗缺口大,亟需大规模干预以减少房颤不良后果。

研究设计与样本

  • 参与者接受结构化问卷、标准12导联心电图、体格检查和采血。
  • 房颤患病率定义为心电图检测或自我报告,并按抽样权重、无应答及人口年龄性别分布进行加权估计。

主要发现

  • 加权房颤患病率为1.8%(95%CI 1.7%至1.9%),不同地理区域间波动于0.9%至2.4%。
  • 45-54岁年龄组男女房颤患病率分别为0.8%和0.6%,≥75岁组分别升至5.4%和4.9%。
  • 房颤知晓率总体从45-54岁组的65.3%降至≥75岁组的53.9%,男性58.5%、女性68.8%,城市78.3%、农村35.3%。
  • 高危房颤患者中仅6.0%接受抗凝治疗。

临床怎么用

  • 在45岁及以上成人中应重视房颤筛查,尤其关注高龄、农村居民等知晓率较低人群。
  • 对高危房颤患者需评估抗凝治疗指征,当前抗凝治疗比例极低,应加强规范抗凝管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine AF prevalence and gaps in atrial fibrillation (AF) awareness and management in China. METHODS: We conducted a community-based survey of 47 841 adults (age ≥45 years) in seven geographic regions of China between 2014 and 2016. Participants underwent a structured questionnaire, a standard 12-lead ECG, physical examination and blood sampling. AF prevalence, defined by either ECG detection or self-report, was estimated according to sampling weights, non-response and age and sex distribution of the population. We used multivariable logistic regression to estimate associations among sociodemographic, clinical and geographic factors with the AF prevalence, awareness and treatment. RESULTS: The weighted AF prevalence was 1.8% (95% CI 1.7% to 1.9%), but varied from 0.9% to 2.4% across geographical regions and equates to being present in an estimated 7.9 (95% CI 7.4 to 8.4) million people in China. Among men and women, the AF prevalence increased from 0.8% and 0.6% in the age group 45-54 years to 5.4% and 4.9% in the age group ≥75 years, respectively. Proportions of people who were aware of having AF decreased overall from 65.3% in 45-54 year-olds to 53.9% in ≥75 year-olds and varied between sex (men 58.5%, women 68.8%) and residency status (urban 78.3%, rural 35.3%). Only 6.0% of patients with high-risk AF received anticoagulation therapy. CONCLUSIONS: AF prevalence is higher than previously reported in China, with low awareness and large treatment gaps. Large-scale efforts are urgently needed to reduce AF adverse consequences.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Du X, Guo L, Xia S, et al. Atrial fibrillation prevalence, awareness and management in a nationwide survey of adults in China. Heart. 2021. PMID: 33509976. doi:10.1136/heartjnl-2020-317915

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。